Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2010-06-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1002372107PMID 20616008PMCID PMC2919974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinase‐2 expression in stromal tissues is a consistent prognostic factor in stage II colon cancer

  2009cited by this paper
• Mouse models of colon cancer.

  2009cited by this paper
• Learning therapeutic lessons from metastasis suppressor proteins

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• Macrophage inflammatory protein-1 delta: a novel osteoclast stimulating factor secreted by renal cell carcinoma bone metastasis.

  2008cited by this paper
• Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Faculty Opinions recommendation of Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.

  2008cited by this paper
• MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not

  2008cited by this paper
• Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcΔ716 mice

  2008cited by this paper
• Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.

  2007cited by this paper
• Clinical Relevance of the Expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA Tissue Samples from Colorectal Liver Metastases

  2007cited by this paper
• Keeping out the bad guys: gateway to cellular target therapy.

  2007cited by this paper
• Prognostic significance of matrix metalloproteinases‐1, ‐2, ‐7 and ‐13 and tissue inhibitors of metalloproteinases‐1, ‐2, ‐3 and ‐4 in colorectal cancer

  2007cited by this paper
• Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.

  2007cited by this paper
• SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion

  2007cited by this paper
• Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

  2006cited by this paper
• Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy

  2006cited by this paper
• New signals from the invasive front

  2006cited by this paper
• Bridged Piperazines and Piperidines as CCR1 Antagonists with Oral Activity in Models of Arthritis and Multiple Sclerosis

  2006cited by this paper
• RNA repair for haemophilia A

  2006cited by this paper
• Tumour–host interactions: implications for developing anti-cancer therapies

  2006cited by this paper
• Molecular cloning and characterization of rat CCL9 (MIP-1gamma), the ortholog of mouse CCL9.

  2005cited by this paper
• VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

  2005cited by this paper
• Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop.

  2005cited by this paper
• The clinical potential of chemokine receptor antagonists.

  2005cited by this paper
• Matrix metalloproteinases in colorectal cancer: Is it worth talking about?

  2004cited by this paper
• Cancer and the chemokine network

  2004cited by this paper
• Metastasis: Dissemination and growth of cancer cells in metastatic sites

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

  2002cited by this paper
• Hemofiltrate CC chemokines with unique biochemical properties: HCC‐1/CCL14a and HCC‐2/CCL15

  2001cited by this paper
• Recent advances in chemokines and chemokine receptors.

  1999cited by this paper
• Molecular Cloning and Functional Characterization of Human MIP-1δ, a New C–C Chemokine Related to Mouse CCF-18 and C10

  1998cited by this paper
• Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.

  1998cited by this paper
• MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.

  1998influential reference
• Impaired Host Defense, Hematopoiesis, Granulomatous Inflammation and Type 1–Type 2 Cytokine Balance in Mice Lacking CC Chemokine Receptor 1

  1997cited by this paper
• Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.

  1997influential reference
• Overexpression of matrix metalloproteinase‐2 and tissue inhibitor of matrix metalloproteinase‐2 in liver from patients with gastrointestinal adenocarcinoma and no detectable metastasis

  1997cited by this paper
• Unaltered Secretion of β-Amyloid Precursor Protein in Gelatinase A (Matrix Metalloproteinase 2)-deficient Mice*

  1997influential reference
• Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.

  1995cited by this paper
• Cancer statistics

  1989cited by this paper

• Particulate matter-induced lung cancer metastasis is inhibited by ginsenoside Rg3.

  2025cites this paper
• Immune microenvironment regulation and clinical immunotherapy strategies of metastatic liver cancer

  2025cites this paper
• A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution

  2025cites this paper
• Tumor-derived CCL5 recruits CCR1+ macrophages to suppress apoptosis and drive proliferation in duodenal adenocarcinoma.

  2025cites this paper
• System pharmacology reveals the mechanism of action of Shengbai Oral Liquid alleviates chemotherapy-induced leukopenia by interfering the Pro-Platelet Basic Protein: Integrated network study of multi-omics.

  2025cites this paper
• Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis

  2025cites this paper
• TRIM26 deficiency potentially suppresses colorectal cancer liver metastasis through NF-κB-mediated M1-like tumor-associated macrophage polarization

  2025cites this paper
• Macrophages in the premetastatic and metastatic niche: key functions and therapeutic directions

  2025cites this paper
• Liver Extracellular Matrix in Colorectal Liver Metastasis

  2025cites this paper
• Invasion and metastasis in cancer: molecular insights and therapeutic targets

  2025cites this paper
• Chemokine systems in oncology: From microenvironment modulation to nanocarrier innovations.

  2024cites this paper
• Human blood cell transcriptomics unveils dynamic systemic immune modulation along colorectal cancer progression

  2024cites this paper
• Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis

  2024cites this paper
• Gram-Negative Microflora Dysbiosis Facilitates Tumor Progression and Immune Evasion by Activating the CCL3/CCL5–CCR1–MAPK–PD-L1 Pathway in Esophageal Squamous Cell Carcinoma

  2024cites this paper
• Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment

  2024cites this paper
• Chemokine‑ and chemokine receptor-based subtypes predict prognosis, immunotherapy and chemotherapy response in colorectal cancer patients.

  2024cites this paper
• High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy

  2024cites this paper
• Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM)

  2024cites this paper
• The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review

  2024cites this paper
• Origin, Metastasis, Harm, Recognition and Capture, and Elimination of Circulating Tumor Cells

  2024cites this paper
• Characterizing ligand-receptor interactions and unveiling the pro-tumorigenic role of CCL16-CCR1 axis in the microenvironment of hepatocellular carcinoma

  2024cites this paper
• Molecular Mechanisms of Colorectal Liver Metastases

  2023cites this paper
• Weaving the nest: extracellular matrix roles in pre-metastatic niche formation

  2023cites this paper
• The Chemokine Receptor CCR1 Mediates Microglia Stimulated Glioma Invasion

  2023influential citation
• Moxibustion attenuates liver metastasis of colorectal cancer by regulating gut microbial dysbiosis.

  2023cites this paper
• Spleen-Derived CCL9 Recruits MDSC to Facilitate Tumor Growth in Orthotopic Hepatoma Mice

  2023cites this paper
• GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis.

  2023cites this paper
• A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer

  2023cites this paper
• Three-Dimensional Breast Cancer Model to Investigate CCL5/CCR1 Expression Mediated by Direct Contact between Breast Cancer Cells and Adipose-Derived Stromal Cells or Adipocytes

  2023cites this paper
• Coordinated Regulation of Myeloid-Derived Suppressor Cells by Cytokines and Chemokines

  2022cites this paper
• Chemokine Clouding and Liver Cancer Heterogeneity: Does it Impact Clinical Outcomes?

  2022cites this paper
• Eggshell membrane modulates gut microbiota to prevent murine pre‐cachexia through suppression of T helper cell differentiation

  2022cites this paper
• Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma

  2022cites this paper
• Colorectal liver metastasis: molecular mechanism and interventional therapy

  2022cites this paper
• Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers.

  2022cites this paper
• Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies

  2022cites this paper
• Evolving polarisation of infiltrating and alveolar macrophages in the lung during metastatic progression of melanoma suggests CCR1 as a therapeutic target

  2022cites this paper
• Role of chemokines in the crosstalk between tumor and tumor-associated macrophages

  2022cites this paper
• Notch signaling mutations increase intra-tumor chemokine expression and predict response to immunotherapy in colorectal cancer

  2022cites this paper
• The Hepatic Pre-Metastatic Niche

  2022cites this paper
• Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy

  2022cites this paper
• Robust prognostic model based on immune infiltration‐related genes and clinical information in ovarian cancer

  2022cites this paper
• Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy

  2021cites this paper
• Suppression of C-C chemokine receptor 1 is a key regulation for colon cancer chemoprevention in AOM/DSS mice by fucoxanthin.

  2021cites this paper
• Chemokine Receptor Antagonists: Role in Oncology

  2021cites this paper
• Microbeam Radiotherapy—A Novel Therapeutic Approach to Overcome Radioresistance and Enhance Anti-Tumour Response in Melanoma

  2021cites this paper
• Genetic variants of EML1 and HIST1H4E in myeloid cell-related pathway genes independently predict cutaneous melanoma-specific survival.

  2021cites this paper
• OTT_A_301371 3013..3036

  2021cites this paper
• Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer

  2021cites this paper
• Targeting the STAT6 signaling pathway as a therapy against colon cancer

  2021cites this paper
• Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity

  2021cites this paper
• RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathways

  2021cites this paper
• The role of myeloid‐derived suppressor cells in gastrointestinal cancer

  2021cites this paper
• Gene and Protein Expression Is Altered by Ascorbate Availability in Murine Macrophages Cultured under Tumour-Like Conditions

  2021cites this paper
• CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets

  2021cites this paper
• Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance

  2021cites this paper
• Upregulation of TRPM8 can promote the colon cancer liver metastasis through mediating Akt/GSK‐3 signal pathway

  2021cites this paper
• Localization-Specific Expression of CCR1 and CCR5 by Mast Cell Progenitors

  2020cites this paper
• The Engagement Between MDSCs and Metastases: Partners in Crime

  2020cites this paper
• CCL7 Signaling in the Tumor Microenvironment.

  2020cites this paper
• Emerging immunotherapies for metastasis

  2020cites this paper
• Transforming Grown Factor-β Signaling in Immunity and Cancer

  2020cites this paper
• Establishment of a prognostic model based on immune in�ltration-related genes and clinical information in ovarian cancer

  2020cites this paper
• CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4

  2020cites this paper
• Regulatory T cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis.

  2020cites this paper
• Identifying Molecular Determinants of Immune Rejection in Pancreatic Cancer

  2020cites this paper
• The cellular and molecular components involved in pre-metastatic niche formation in colorectal cancer liver metastasis

  2020influential citation
• Xiaoyaosan, a traditional Chinese medicine, inhibits the chronic restraint stress-induced liver metastasis of colon cancer in vivo

  2020cites this paper
• Combinatorial Immunotherapies for Metastatic Colorectal Cancer

  2020cites this paper
• The spleen contributes to the increase in PMN-MDSCs in orthotopic H22 hepatoma mice.

  2020cites this paper
• Prognosis and targeting of pre-metastatic niche.

  2020cites this paper
• SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7

  2020cites this paper
• Immune Selection Pressure Contributes to Pancreatic Cancer Immune Evasion

  2020cites this paper
• The unique immune microenvironment of liver metastases: challenges and opportunities.

  2020cites this paper
• Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice.

  2020cites this paper
• Context Drives Diversification of Monocytes and Neutrophils in Orchestrating the Tumor Microenvironment

  2019cites this paper
• MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation

  2019cites this paper
• Effect of Chemokine (C-C Motif) Ligand 7 (CCL7) and Its Receptor (CCR2) Expression on Colorectal Cancer Behaviors

  2019cites this paper
• Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy

  2019cites this paper
• Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells

  2019cites this paper
• Transforming Growth Factor-β Signaling in Immunity and Cancer.

  2019cites this paper
• VEGFR1+ Metastasis–Associated Macrophages Contribute to Metastatic Angiogenesis and Influence Colorectal Cancer Patient Outcome

  2019cites this paper
• Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/β-catenin signaling pathway.

  2019cites this paper
• Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation

  2019cites this paper
• Can Exercise-Induced Modulation of the Tumor Physiologic Microenvironment Improve Antitumor Immunity?

  2019cites this paper
• Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment

  2019cites this paper
• A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells.

  2019cites this paper
• Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor.

  2019cites this paper
• Circulating inflammatory markers and colorectal cancer risk: A prospective case‐cohort study in Japan

  2018cites this paper
• Knockdown of FOXP1 promotes the development of lung adenocarcinoma

  2018cites this paper
• A framework for the development of effective anti-metastatic agents

  2018cites this paper
• Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors

  2018cites this paper
• C‐C chemokine receptor type 1 mediates osteopontin‐promoted metastasis in hepatocellular carcinoma

  2018cites this paper
• Bioengineered cellular and cell membrane‐derived vehicles for actively targeted drug delivery: So near and yet so far

  2018cites this paper
• Loss of NDRG2 in liver microenvironment inhibits cancer liver metastasis by regulating tumor associate macrophages polarization

  2018cites this paper
• Identifying DNA Methylation Modules Associated with a Cancer by Probabilistic Evolutionary Learning

  2018cites this paper
• Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.

  2018cites this paper
• Improving the understanding of platinum sensitivity and the tumour microenvironment in high grade serous ovarian cancer

  2018cites this paper
• Chemotherapy and tumor microenvironment of pancreatic cancer

  2017cites this paper
• Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer

  2017cites this paper